Dipeptidyl Peptidase IV Inhibitor MK-0626 Attenuates Pancreatic Islet Injury in Tacrolimus-Induced Diabetic Rats

BACKGROUND: Tacrolimus (TAC)-induced pancreatic islet injury is one of the important causes of new-onset diabetes in transplant recipients. This study was performed to evaluate whether a dipeptidyl peptidase IV (DPP IV) inhibitor is effective in improving TAC-induced diabetes mellitus by reducing pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Long, Lim, Sun Woo, Doh, Kyoung Chan, Piao, Shang Guo, Jin, Jian, Heo, Seong Beom, Chung, Byung Ha, Yang, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069160/
https://www.ncbi.nlm.nih.gov/pubmed/24959755
http://dx.doi.org/10.1371/journal.pone.0100798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069160/
https://www.ncbi.nlm.nih.gov/pubmed/24959755
http://dx.doi.org/10.1371/journal.pone.0100798

Ejemplares similares